Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 3, 2007, Pages 183-188

  Iseki, Kunitoshi ^a,b   Nakai, Shigeru ^a   Shinzato, Takahiro ^a   Morita, Osamu ^a   Shinoda, Toshio ^a   Kikuchi, Kenjiro ^a   Wada, Atsushi ^a   Kimata, Naoki ^a   Akiba, Takashi ^a  

^a Scientific Academic Committee of the Japanese Society for Dialysis Therapy   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

Cardiovascular disease; Chronic dialysis; Hypertension; Survival

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM; ERYTHROPOIETIN; PHOSPHORUS; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WEIGHT CHANGE;

FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS;

EID: 34248198387     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00479.x     Document Type: Article

References (35)

1. Agarwal R. Hypertension and survival in chronic hemodialysis patients - Past lessons and future opportunities. Kidney Int 2005 67 : 1 13.
2. Port FK, Hulbert-Shearon TE, Wolfe RA et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999 33 : 507 17.
3. Foley RN, Parfrey PS, Harnett JD et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996 49 : 1379 85.
4. Iseki K, Fukiyama K. Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 1996 50 : 1672 5.
5. Iseki K, Shinzato T, Nagura Y, Akiba T. Factors influencing long-term survival in patients on chronic dialysis. Clin Exp Nephrol 2004 8 : 89 97.
6. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population. Hypertension 2005 45 : 811 17.
7. Goodkin DA, Young EW, Kurokawa K et al. Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis 2004 44 : S16 S21.
8. Degoulet P, Legrain M, Reach I et al. Mortality risk factors in patients treated by chronic hemodialysis: report of the Diaphane Collaborative Study. Nephron 1982 31 : 103 10.
9. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990 15 : 458 82.
10. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993 44 : 115 19.
11. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999 55 : 648 58.
12. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999 14 : 1956 60.
13. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003 63 : 793 08.
14. Charra B, Calemand E, Ruffet M et al. Survival as an index of adequacy of dialysis. Kidney Int 1992 41 : 1286 91.
15. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998 32 : 720 4.
16. Odaka M. Mortality in chronic dialysis patients in Japan. Am J Kidney Dis 1990 15 : 410 13.
17. Teraoka S, Toma H, Nihei H et al. Current status of renal replacement therapy in Japan. Am J Kidney Dis 1995 25 : 151 64.
18. Shinzato T, Nakai S, Akiba T et al. Survival in long-term hemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1996 11 : 2139 42.
19. Shinzato T, Nakai S, Akiba T et al. Current status of renal replacement therapy in Japan: results of the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1996 11 : 2143 50.
20. Shinzato T, Nakai S, Akiba T et al. Report on the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996. Kidney Int 1999 55 : 700 12.
21. Akiba T, Nakai S, Shinzato T et al. Why has the gross mortality of dialysis patients increased in Japan? Kidney Int 2000 57 : S60 S5.
22. Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK. Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. Am J Nephrol 2001 21 : 280 8.
23. Nakai S, Shinzato T, Sanaka T et al. The current state of chronic dialysis treatment in Japan (as of December 31, 2001). J Jpn Soc Dial Ther 2003 36 : 1 31.
24. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000 35 : S117 S31.
25. Guidelines Subcommittee of the Japanese Society of Hypertension. Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2000). Guidelines Subcommittee of the Japanese Society of Hypertension. Tokyo, Japan. 2000.
26. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003 42 : 1206 52.
27. Iseki K, Miyasato F, Tokuyama K et al. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 1997 51 : 1212 17.
28. Vertes V, Cangiano L, Berman LB, Gould A. Hypertension in end-stage renal disease. N Engl J Med 1969 280 : 978 81.
29. Lopez-Gomez JM, Villaverde M, Jofre R, Rodriguez-Benitez R, Perez-Garcia R. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int 2005 67 : S63 S8.
30. Kurokawa K. Salt, kidney and hypertension: why and what to learn from genetic analyses? Nephron 2001 89 : 369 76.
31. Iseki K, Iseki C, Itoh K et al. Urinary excretion of sodium and potassium in a screened cohort in Okinawa, Japan. Hypertens Res 2002 25 : 731 6.
32. Khosla UM, Johnson RJ. Editorial: hypertension in the hemodialysis patient and the "Lag Phenomenon": insights into pathophysiology and clinical management. Am J Kidney Dis 2004 43 : 739 51.
33. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002 347 : 2010 19.
34. Tozawa M, Iseki K, Iseki C et al. Analysis of drug prescription in patients on chronic hemodialysis. Nephrol Dial Transplant 2002 17 : 1819 24.
35. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004 66 : 1212 20.